Xodo Andrea, D'Oria Mario, Squizzato Francesco, Antonello Michele, Grego Franco, Bonvini Stefano, Milite Domenico, Frigatti Paolo, Cognolato Diego, Veraldi Gian Franco, Perkmann Reinhold, Garriboli Luca, Jannello Antonio Maria, Lepidi Sandro
Vascular and Endovascular Surgery Division, Padova University, School of Medicine, Padova, Italy.
Division of Vascular and Endovascular Surgery, Cardiovascular Department, University of Trieste Medical School, Trieste, Italy.
J Vasc Surg. 2022 Jan;75(1):153-161.e2. doi: 10.1016/j.jvs.2021.05.053. Epub 2021 Jun 26.
To report the early and mid-term outcomes following open surgical conversion (OSC) after failed endovascular aortic repair (EVAR) using data from a multicentric registry.
A retrospective study was carried out on consecutive patients undergoing OSC after failed EVAR at eight tertiary vascular units from the same geographic area in the North-East of Italy, from April 2005 to November 2019. Study endpoints included early and follow-up outcomes.
A total of 144 consecutive patients were included in the study. Endoleaks were the most common indication for OSC (50.7%), with endograft infection (24.6%) and occlusion (21.9%) being the second most prevalent causes. The overall rate of 30-day all-cause mortality was 13.9% (n = 20); 32 patients (22.2%) experienced at least one major complication. Mean length of stay was 13 ± 12.7 days. On multivariate logistic regression, age (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.01-1-19; P = .02), renal clamping time (OR, 1.07; 95% CI, 1.02-1.13; P = .01), and suprarenal/celiac clamping (OR, 6.66; 95% CI, 1.81-27.1; P = .005) were identified as independent predictors of perioperative major complications. Age was the only factor associated with perioperative mortality at 30 days. Renal clamping time >25 minutes had sensitivity of 65% and specificity of 70% in predicting the occurring of major adverse events (area under the curve, 0.72; 95% CI, 0.61-0.82). At 5 years, estimated survival was significantly lower for patients treated due to aortic rupture/dissection (28%; 95% CI, 13%-61%), compared with patients in whom the indication for treatment was endoleak (54%; 95% CI, 40%-73%), infection (53%; 95% CI, 30%-94%), or thrombosis (82%; 95% CI, 62%-100%; P = .0019). Five-year survival rates were significantly lower in patients who received emergent treatment (28%; 95% CI, 14%-55%) as compared with those who were treated in an urgent (67%; 95% CI, 48%-93%) or elective setting (57%; 95% CI, 43%-76%; P = .00026). Subjects who received suprarenal/celiac (54%; 95% CI, 36%-82%) or suprarenal (46%; 95% CI, 34%-62%) aortic cross-clamping had lower survival rates at 5 years than those whose aortic-cross clamp site was infrarenal (76%; 95% CI, 59%-97%; P = .041). Using multivariate Cox proportional hazard, older age and emergency setting were independently associated with higher risk for overall 5-year mortality.
OSC after failed EVAR was associated with relatively high rates of early morbidity and mortality, particularly for emergency setting surgery. Endoleaks with secondary sac expansion were the main indication for OSC, and suprarenal aortic cross-clamping was frequently required. Endograft infection and emergent treatment remained associated with poorer short- and long-term survival.
利用多中心登记处的数据报告血管腔内主动脉修复术(EVAR)失败后进行开放手术转换(OSC)的早期和中期结果。
对2005年4月至2019年11月期间,意大利东北部同一地理区域的8个三级血管单元中,EVAR失败后接受OSC的连续患者进行了一项回顾性研究。研究终点包括早期和随访结果。
共有144例连续患者纳入研究。内漏是OSC最常见的指征(50.7%),其次是移植物感染(24.6%)和闭塞(21.9%)。30天全因死亡率为13.9%(n = 20);32例患者(22.2%)发生至少一种主要并发症。平均住院时间为13±12.7天。多因素logistic回归分析显示,年龄(比值比[OR],1.09;95%置信区间[CI],1.01 - 1.19;P = .02)、肾动脉阻断时间(OR,1.07;95% CI,1.02 - 1.13;P = .01)和肾上/腹腔动脉阻断(OR,6.66;95% CI,1.81 - 27.1;P = .005)是围手术期主要并发症的独立预测因素。年龄是30天围手术期死亡率的唯一相关因素。肾动脉阻断时间>25分钟预测主要不良事件发生的敏感度为65%,特异度为70%(曲线下面积,(AUC)0.72;95% CI,0.61 - 0.82)。5年时,因主动脉破裂/夹层接受治疗的患者估计生存率(28%;95% CI,13% - 61%)显著低于因内漏(54%;95% CI,40% - 73%)、感染(53%;95% CI,30% - 94%)或血栓形成(82%;95% CI,62% - 100%;P = .0019)接受治疗的患者。与接受紧急治疗(28%;95% CI,14% - 55%)的患者相比,接受紧急(67%;95% CI,48% - 93%)或择期治疗(57%;95% CI,43% - 76%;P = .00026)的患者5年生存率显著降低。接受肾上/腹腔动脉(54%;95% CI,36% - 82%)或肾动脉以上(46%;95% CI,34% - 62%)主动脉交叉阻断的患者5年生存率低于肾动脉以下主动脉交叉阻断的患者(76%;95% CI,59% - 97%;P = .041)。多因素Cox比例风险分析显示,年龄较大和紧急治疗与5年总死亡率较高独立相关。
EVAR失败后行OSC与相对较高的早期发病率和死亡率相关,尤其是急诊手术。继发瘤体扩张的内漏是OSC的主要指征,常需要进行肾动脉以上主动脉交叉阻断。移植物感染和急诊治疗仍然与较差的短期和长期生存率相关。